Prevalence of Oral Lichen Planus in Diabetes Mellitus: a Meta-Analysis Study

Hamid Reza Mozaffari, Roohollah Sharifi, Masoud Sadeghi, Hamid Reza Mozaffari, Roohollah Sharifi, Masoud Sadeghi

Abstract

Background: Oral lichen planus (OLP) is associated with various other systemic conditions such as hypertension, diabetes mellitus (DM). This study evaluated the prevalence of OLP in DM patients compared with non-diabetic control subjects in a meta-analysis study.

Methods: In this study from January 1973 to August 2016, we searched the studies in Web of Science, Medline/PubMed, Scopus, Science direct, SID (Scientific Information Database), Cochrane and Embase databases. Strategy search was the Medical Subject Heading (MeSH) term oral lichen planus or oral mucosa combined with diabetes in PubMed and this search in other databases. Heterogeneity between estimates was evaluated by the Q and I2 statistic. Also, publication bias was assessed through funnel plot analysis with the Kendall's and Egger's tests.

Results: From 831 studies were identified with different search strategies, 11 studies met the criteria to be included in meta-analysis (11 case-control studies). The overall prevalence of OLP in 11 studies with 4937 DM patients and 3698 control subjectswas 1.5% and 0.75%, respectively. In this meta-analysis, the OR in prevalence of OLP in DM patients compared with control subjects was 1.584 (95%CI1.013-2.477; P=0.044) with a low level of heterogeneity (I2 = 0%) that the result showed the prevalence of OLP in DM patients is significantly more than control subjects.

Conclusions: This meta-analysis study showed an association between OLP with DM, whereas this association was no significant in previous studies, it was probably because different selecting of age, sex, type of DM, medications and criteria. Totally, the meta-analysis showed the risk of OLP in DM was higher compared with control subjects.

Keywords: Diabetes mellitus; Meta-analysis study; Oral lichen planus.

Conflict of interest statement

• Conflict of interest: none declared

Figures

Figure 1
Figure 1
Flow diagram of study
Figure 2
Figure 2
Forest plot of odds ratio of prevalence of oral lichen planus (95% confidence intervals) in diabetes mellitus patients compared with control subjects (Favours A: Patients; Favours B: Controls)
Figure 3
Figure 3
Funnel plot of the included studies in the meta-analysis investigating the prevalence of lichen planus in diabetes mellitus patients

References

    1. Mozaffari HR, Rahmani M, Rezaei F, Sadeghi M, Sharifi R, Ejtehadi A. Evaluation of oral lichen planus frequency in patients referred to pathology centers of Kermanshah city, during 2008 to 2011. Sch J App Med Sci. 2016;4(6E):2200–2.
    1. Carazzo M, Thorpe R. Oral lichen planus: a review. Minerva Stomatol. 2009;58(10):519–37.
    1. Shen ZY, Liu W, Zhu LK, Feng JQ, Tang GY, Zhou ZT. A retrospective clinicopathological study on oral lichen planus and malignant transformation: Analysis of 518 cases. Med Oral Patol Oral Cir Bucal. 2012;17(6):e943–7.
    1. Torrente-Castells E, Figueiredo R, Berini-Aytés L, Gay-Escoda C. Clinical features of oral lichen planus. A retrospective study of 65 cases. Med Oral Patol Oral Cir Bucal. 2010;15(5):e685–90.
    1. Canter PH, Wider B, Ernst E. The antioxidant Vitamins A, C, E and selenium in the treatment of arthritis: A systematic review of randomized clinical trials. Rheumatology (Oxford) 2007;46(8):1223–33.
    1. Arrieta-Blanco JJ, Bartolomé-Villar B, Jiménez-Martinez E, Saavedra-Vallejo P, Arrieta-Blanco FJ. Bucco-dental problems in patients with Diabetes Mellitus (I) :Index of plaque and dental caries. Med Oral. 2003;8(2):97–109.
    1. Black JM, Hawks JH. Medical-Surgical Nursing-Clinical Management for Positive Outcomes. 8th ed. London: Saunders; 2009. p. 1062.
    1. Zaccardi F, Webb DR, Yates T, Davies MJ. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J. 2016;92(1084):63–9.
    1. Marín-Peñalver JJ, Martín-Timón I, Sevillano-Collantes C, Del Cañizo-Gómez FJ. Update on the treatment of type 2 diabetes mellitus. World J Diabetes. 2016;7(17):354–95.
    1. Krupaa RJ, Sankari SL, Masthan KM, Rajesh E. Oral lichen planus: An overview. J Pharm Bioallied Sci. 2015;7(Suppl 1):S158–61.
    1. Petrou-Amerikanou C, Markopoulos AK, Belazi M, Karamitsos D, Papanayotou P. Prevalence of oral lichen planus in diabetes mellitus according to the type of diabetes. Oral Dis. 1998;4(1):37–40.
    1. Kaomongkolgit R. Oral lichenoid drug reaction associated with antihypertensive and hypoglycemic drugs. J Drugs Dermatol. 2010;9(1):73–5.
    1. Al-Maweri SA, Ismail NM, Ismail AR, Al-Ghashm A. Prevalence of oral mucosal lesions in patients with type 2 diabetes attending hospital universiti sains malaysia. Malays J Med Sci. 2013;20(4):39–46.
    1. Bastos AS, Leite AR, Spin-Neto R, Nassar PO, Massucato EM, Orrico SR. Diabetes mellitus and oral mucosa alterations: prevalence and risk factors. Diabetes Res Clin Pract. 2011;92(1):100–5.
    1. Albrecht M, Bánóczy J, Dinya E, Tamás G., Jr Occurrence of oral leukoplakia and lichen planus in diabetes mellitus. J Oral Pathol Med. 1992;21(8):364–6.
    1. Guggenheimer J, Moore PA, Rossie K, Myers D, Mongelluzzo MB, Block HM, et al. Insulin-dependent diabetes mellitus and oral soft tissue pathologies: II. Prevalence and characteristics of Candida and Candidal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89(5):570–6.
    1. Van Dis ML, Parks ET. Prevalence of oral lichen planus in patients with diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79(6):696–700.
    1. Mohsin SF, Ahmed SA, Fawwad A, Basit A. Prevalence of oral mucosal alterations in type 2. diabetes mellitus patients attending a diabetic center. Pak J Med Sci. 2014;30(4):716–9.
    1. Saini R, Al-Maweri SA, Saini D, Ismail NM, Ismail AR. Oral mucosal lesions in non oral habit diabetic patients and association of diabetes mellitus with oral precancerous lesions. Diabetes Res Clin Pract. 2010;89(3):320–6.
    1. Borghelli RF, Pettinari IL, Chuchurru JA, Stirparo MA. Oral lichen planus in patients with diabetes. An epidemiologic study. Oral Surg Oral Med Oral Pathol. 1993;75(4):498–500.
    1. Borhan Mojabi K, Esfahani M, Bokharaee MM. Evaluation of median rhomboid glossitis and oral lichen planus in patients with diabetes mellitus. J Qazvin Univ Med Sci. 2009;13(1):56–60.
    1. Zareei MR, Shirei R. Assessment of the prevalence of oral lichen planus in diabetic patients. Journal of Dental School. 2000;18(2):137–43.
    1. Potts AJ, Hamburger J, Scully C. The medication of patients with oral lichen planus and the association of nonsteroidal anti-inflammatory drugs with erosive lesions. Oral Surg Oral Med Oral Pathol. 1987;64(5):541–3.
    1. Robertson WD, Wray D. Ingestion of medication among patients with oral keratoses including lichen planus. Oral Surg Oral Med Oral Pathol. 1992;74(2):183–5.
    1. Ara SA, Mamatha GP, Rao B. Incidence of diabetes mellitus in patients with diabetes mellitus. J Dental Clin. 2011;3(1):29–33.
    1. Gupta S, Jawanda MK. Oral Lichen Planus: An Update on Etiology, Pathogenesis, Clinical Presentation, Diagnosis and Management. Indian J Dermatol. 201;60(3):222–9.
    1. Shafer WG, Hine MK, Levy BM. Shafer’s textbook of oral pathology. 6th ed. Noida, India: Elsevier publications; 2009. p. 800.
    1. Ahmed I, Nasreen S, Jehangir U, Wahid Z. Frequency of oral lichen planus in patients withnoninsulin dependent diabetes mellitus. Journal of Pakistan Association of Dermatologists. 2012;22(1):30–34.
    1. Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002;97(3):604–11.
    1. Sykes LM, Sukha A. Potential risk of serious oral infections in the diabetic patient: a clinical report. J Prosthet Dent. 2001;86(6):569–73.
    1. Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(Suppl):S25e1–12.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj